Key Takeaways
- • Pluro Fertility raises ₹125 crore ($14-15 million) in Series A funding led by Bessemer Venture Partners at a ₹1,000 crore ($112 million) valuation, establishing a significant capital position in India's fertility care market.
- • Company operates a clinical partnership model enabling independent IVF specialists to retain clinical autonomy while accessing centralized operational, compliance, technology, and marketing support—differentiating its approach from traditional consolidation models.
- • Aggressive expansion roadmap targets 25 fertility centres by March 2026 and 100+ clinics within three years, leveraging capital to scale network and strengthen reproductive science capabilities across India.
- • Funding syndicate includes prominent healthcare and fintech investors: Vikram Chatwal (MediAssist), Dharmil Sheth and Hardik Dedhia (PharmEasy/All Home), Salil Musale (Astarc Ventures), Shalibhadra Shah and Niket Shah (Motilal Oswal), and Karan Kapur (K Hospitality).
- • Founded in 2025 by three physicians—Dr Jaydeep Tank, Dr Parikshit Tank, and Dr Bhaskar Shah—the startup targets accessibility and quality improvement in reproductive healthcare across India's underserved fertility market.
Summary
Pluro Fertility and IVF has closed a ₹125 crore Series A funding round led by tier-one venture capital firm Bessemer Venture Partners, valuing the healthcare startup at ₹1,000 crore. The round marks a significant institutional validation of the company's clinical partnership model in India's fertility care sector, drawing participation from multiple notable healthcare and financial services entrepreneurs and investors.
The company's business model differentiates itself through a partnership-first approach rather than traditional clinic acquisition. Pluro manages non-clinical operations for affiliated fertility specialists—including practice management, compliance, technology infrastructure, and marketing support—while allowing partner physicians to maintain clinical independence and decision-making autonomy. This structure addresses a gap in India's fragmented fertility market, where independent practitioners lack access to enterprise-grade operational and technological resources.
Capital deployment targets rapid geographic expansion and clinical capability enhancement. Pluro plans to open 25 fertility centres across India by March 2026 and scale to over 100 clinics within a three-year horizon. The fresh capital will fund network expansion, technology investments, and deepening of clinical capabilities in reproductive science. Given the company's founding in 2025 by three physicians—Dr Jaydeep Tank, Dr Parikshit Tank, and Dr Bhaskar Shah—the clinical credibility embedded in leadership positions the platform to execute on specialized medical scaling.
The investor syndicate reflects healthcare sector conviction: Vikram Chatwal's involvement through MediAssist signals healthcare operations expertise, while PharmEasy/All Home co-founders Dharmil Sheth and Hardik Dedhia bring digital health distribution experience. Additional backing from Astarc Ventures, Motilal Oswal (via Shalibhadra Shah and Niket Shah), and hospitality sector investor Karan Kapur demonstrates cross-sector interest in fertility care consolidation at the operational level.
For institutional investors monitoring India's healthcare infrastructure and fintech-enabled service businesses, Pluro represents a capital-efficient model for addressing reproductive healthcare accessibility within a large, underserved market.
The company's business model differentiates itself through a partnership-first approach rather than traditional clinic acquisition. Pluro manages non-clinical operations for affiliated fertility specialists—including practice management, compliance, technology infrastructure, and marketing support—while allowing partner physicians to maintain clinical independence and decision-making autonomy. This structure addresses a gap in India's fragmented fertility market, where independent practitioners lack access to enterprise-grade operational and technological resources.
Capital deployment targets rapid geographic expansion and clinical capability enhancement. Pluro plans to open 25 fertility centres across India by March 2026 and scale to over 100 clinics within a three-year horizon. The fresh capital will fund network expansion, technology investments, and deepening of clinical capabilities in reproductive science. Given the company's founding in 2025 by three physicians—Dr Jaydeep Tank, Dr Parikshit Tank, and Dr Bhaskar Shah—the clinical credibility embedded in leadership positions the platform to execute on specialized medical scaling.
The investor syndicate reflects healthcare sector conviction: Vikram Chatwal's involvement through MediAssist signals healthcare operations expertise, while PharmEasy/All Home co-founders Dharmil Sheth and Hardik Dedhia bring digital health distribution experience. Additional backing from Astarc Ventures, Motilal Oswal (via Shalibhadra Shah and Niket Shah), and hospitality sector investor Karan Kapur demonstrates cross-sector interest in fertility care consolidation at the operational level.
For institutional investors monitoring India's healthcare infrastructure and fintech-enabled service businesses, Pluro represents a capital-efficient model for addressing reproductive healthcare accessibility within a large, underserved market.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.